Zdrowie i gospodarka · 02/08/2024
Collaboration Opportunity for Combination of Vaccine With Adoptive Cell Therapies Made at NCI for the Treatment of Solid Cancers
The National Cancer Institute's Surgery Branch is seeking a private sector partner to collaborate on a Phase-I human clinical trial for solid cancers using a Good Manufacturing Practice-grade vaccine.